Sign in

Giulio Francesco Romiti

@giuliofromiti.bsky.social
250 followers 303 following 18 posts

🥼 MD, PhD, FESC | 🔍 Devoted to Clinical Research with a focus on🫀

PostsRepliesMedia
Giulio Francesco Romiti @giuliofromiti.bsky.social · 19/01/2026
ALONE-AF and OCEAN trials question the need for long-term #OAC after successful #AF ablation - how should practice change? In this piece in @natrevcardiol.nature.com, we highlight open questions, and the need for a shared-decision making process⬇️ @mproiettimd.bsky.social #CardioSky
nature.com
000
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 12/09/2025
🌏 Are Asian patients with #AF at higher risk of bleeding? ⬇️ 📌 Kang and colleagues compared East Asian and white Europeans 🩸 East Asian had lower 5-year incidence of bleeding, but a trend towards ⬆️ ICH 🆓 on TH! 👉 www.thieme-connect.de/products/ejo... #HemeSky @liverpoolccs.bsky.social
053
Giulio Francesco Romiti @giuliofromiti.bsky.social · 03/06/2025
You can still register for the upcoming ESC @escardio.bsky.social Council on Stroke #Webinar! 📌 We will cover #multimorbidity and its impact on #stroke prevention and management 📆 27 June 2025, 18:00 (CEST) FREE Registration 👉 esc365.escardio.org/event/1984 #MedSky #CardioSky #NeuroSky
esc365.escardio.org
Multimorbidity in stroke risk and management: harnessing novel technologies for risk assessment and management webinar on ESC 365
Access this webinar on Multimorbidity in stroke risk and management: harnessing novel technologies for risk assessment and management and more with Professor Y. Guo (China,CN), Professor G. Lip (Unit...
022
Reposted by Giulio Francesco Romiti
Giulio Francesco Romiti @giuliofromiti.bsky.social · 11/04/2025
📣 Interested in #Multimorbidity in #Stroke? 🧠 📌 Sign up to the next @ESCStrokeChair webinar to learn more on the impact of multimorbidity on stroke prevention and management! 📆 27 June 2025, 18:00 (Central European Summer Time) Free Registration 👉 esc365.escardio.org/event/1984
021
Giulio Francesco Romiti @giuliofromiti.bsky.social · 11/04/2025
📣 Interested in #Multimorbidity in #Stroke? 🧠 📌 Sign up to the next @ESCStrokeChair webinar to learn more on the impact of multimorbidity on stroke prevention and management! 📆 27 June 2025, 18:00 (Central European Summer Time) Free Registration 👉 esc365.escardio.org/event/1984
021
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 06/03/2025
Vasculearn Network & @thjournal.bsky.social have a 🆕🎙️PODCAST "Clot, Clot, who's there?" Is ♀️ sex a true #RiskFactor for #AFib -related #stroke? 🧠💔 🎧 Listen to @giuliofromiti.bsky.social & @gbarnesmd.bsky.social @bcorica.bsky.social ▶️here tinyurl.com/bdesm9su #cardiosky #vascularsky #thrombosky
267
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 19/02/2025
🧠 Monocyte/Macrophage Infiltration in Stroke ⬇️ 📌 Lee et al. analyzed monocyte/macrophage infiltration of thrombi in a model of arterial #thrombosis 📌 Thrombus infiltration may be associated with outcomes in patients with #stroke 👉📖 www.thieme-connect.de/products/ejo... #StrokeSky #MedSky
022
Reposted by Giulio Francesco Romiti
NEJM.org @nejm.org · 11/01/2025
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors. Learn more: nej.md/4h41K6k #MedSky
nej.md
Heart Failure with Preserved Ejection Fraction | NEJM
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes diuretics and SGLT2 inhibitors.
1318
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 11/01/2025
🚨 Clot Waveform Analysis Parameters are associated with Severity of Liver Cirrhosis 📣 📌 Thanapirom et al. show that a hypocoagulable profile based on CWA parameters is associated with advanced-stage cirrhosis 🆓 in TH 👉 www.thieme-connect.de/products/ejo... #HemeSky #LiverSky
022
Reposted by Giulio Francesco Romiti
Giulio Francesco Romiti @giuliofromiti.bsky.social · 27/12/2024
📣 Interested in the Stroke-Heart Syndrome? 📌 If you want to learn more, you can't miss the next ESC Council on #Stroke webinar! 📆 28 January 2025, 18:00 (Central European Time) 🆓Registration 👉 esc365.escardio.org/event/1903 #MedSky #CardioSky #StrokeSky #NeuroSky @escardio.bsky.social
021
Giulio Francesco Romiti @giuliofromiti.bsky.social · 27/12/2024
📣 Interested in the Stroke-Heart Syndrome? 📌 If you want to learn more, you can't miss the next ESC Council on #Stroke webinar! 📆 28 January 2025, 18:00 (Central European Time) 🆓Registration 👉 esc365.escardio.org/event/1903 #MedSky #CardioSky #StrokeSky #NeuroSky @escardio.bsky.social
021
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 21/12/2024
📣 Blood pressure levels are not associated with incidence of AF at screening! ⤵️ 📖 Among >4000 elderly hypertensive pts, detection of AF was 5.8%, with no significant differences according to baseline BP categories 👉 www.thieme-connect.de/products/ejo... #MedSky #CardioSky
043
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 09/12/2024
🫀 What's new in the 2024 ESC guidelines for Atrial Fibrillation? ⤵️ 📌 Authors review the evidence and updates of the new guidelines of #AF Free on TH 👉 www.thieme-connect.com/products/ejo...
thieme-connect.com
The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective
Thieme E-Books & E-Journals
022
Reposted by Giulio Francesco Romiti
NEJM.org @nejm.org · 06/12/2024
Hello, #MedSky community! We’re excited to begin our Bluesky journey. Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
32860187
Giulio Francesco Romiti @giuliofromiti.bsky.social · 06/12/2024
#MedSky, welcome to @nejm.org (And make sure to follow)!
1103
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 06/12/2024
ICYMI: 💊 #DOAC prescribing oversight for off-label dosing in #AF and #VTE ⤵️ 📖 Herron and colleagues showed results of monitoring for off-label DOAC dosing in pts anticoagulated for AF or VTE 👉 www.thieme-connect.de/products/ejo... #HemSky #CardioSky #MedSky @gbarnesmd.bsky.social
023
Reposted by Giulio Francesco Romiti
JAMA @jama.com · 06/12/2024
Barbara Wendelberger, Berry Consultants, discusses Futility in Clinical Trials with JAMA Statistical Editor Roger Lewis. ja.ma/3ZqQV7j
Podcast preview image.
0165
Reposted by Giulio Francesco Romiti
Dax Kellie @daxkellie.bsky.social · 06/12/2024
`quarto publish` is incredible. I just ran a single function, navigated like 2 prompts, and my presentation slides for my talk next week are now published online with their own url 😲 So simple 🙌 Thanks @posit.co & @quarto.org! #rstats
1252
Reposted by Giulio Francesco Romiti
JAMA @jama.com · 04/12/2024
The JAMA Network is officially on WhatsApp channels. 📱 Follow us there for the latest research and medical news across our 13 journals. ja.ma/3ODwHlx
0102
Giulio Francesco Romiti @giuliofromiti.bsky.social · 06/12/2024
🦠 If you are looking for state-of-the-art review on #sepsis and septic shock, find out this one, just published by the @nejm.org (welcome on Bluesky!): Must read 🔍 www.nejm.org/doi/full/10.... #MedSky
nejm.org
Sepsis and Septic Shock | NEJM
Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing.
030
Reposted by Giulio Francesco Romiti
Geoffrey Barnes, MD, MSc @gbarnesmd.bsky.social · 05/12/2024
Why is it so difficulty to predict thrombosis and bleeding based on clinical factors? Because so many of the risk factors are shared!! This is why we’re all very excited about the promising Factor XI inhibition. Eagerly awaiting more phase 3 data on efficacy
041
Giulio Francesco Romiti @giuliofromiti.bsky.social · 05/12/2024
This is another very interesting study on #GLP-1RA and risk of #Cirrhosis in #MASLD - cohort study, but we really need data on cirrhosis, so very interesting!
020
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 05/12/2024
🤖 The rise of the machines! Machine Learning to predict #Thromboembolic and #Bleeding risk ⤵️ 📌 Ortega-Martorell from @ljmuofficial.bsky.social and colleagues comment a recent paper in #TH and reflect on the role of ML in predicting #thrombosis and bleeding 👉 www.thieme-connect.de/products/ejo...
033
Reposted by Giulio Francesco Romiti
JAMA @jama.com · 04/12/2024
Peptic ulcer disease is associated with increased rates of hospitalization and mortality. This narrative review article covers current evidence regarding the diagnosis and treatment of peptic ulcer disease. ja.ma/4gfnI5N
0195
Giulio Francesco Romiti @giuliofromiti.bsky.social · 03/12/2024
This is very interesting, and consistent with other data on dynamic changes and trajectories in patients with #AFib ⬇️ www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @accintouch.bsky.social #JACCCEP #Epeeps #CardioSky
073
Reposted by Giulio Francesco Romiti
Tara Lech, PharmD @anticoagpharmd.bsky.social · 12/11/2024
💡Check out the BLEED study 🩸🩸 Woman on #Anticoagulation are at risk for ABNORMAL Uterine Bleeding It is important to understand the risk, proactively counsel, provide f/u & screening, and treat when indicated. Women don’t need to suffer 🫶🏼 #AnticoagStewardship pubmed.ncbi.nlm.nih.gov/39505000/
pubmed.ncbi.nlm.nih.gov
Blood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study) - PubMed
Oral anticoagulants (OAC) may exacerbate menstrual bleeding in women of childbearing age; however, the existing literature on this issue has several limitations. This study investigates abnormal uteri...
0249
Giulio Francesco Romiti @giuliofromiti.bsky.social · 02/12/2024
🧠 Recent updates in #stroke and intracerebral haemorrhage covered in this recent @thelancet.bsky.social seminar - definitely worth reading! 👉 www.thelancet.com/journals/lan... #strokesky #medsky
thelancet.com
Stroke
Stroke affects up to one in five people during their lifetime in some high-income countries, and up to almost one in two in low-income countries. Globally, it is the second leading cause of death. Cli...
030
Reposted by Giulio Francesco Romiti
Mamas A. Mamas @mmamas1973.bsky.social · 01/12/2024
PE and clot in transit- a proposed algorithm where role of PE Response Team (PERT) is highlighted for risk stratification and treatment Work led by marco zimarino and friends Link ➡️https://heart.bmj.com/content/early/2024/11/29/heartjnl-2024-324747.long Thank you for inviting me to contribute
1194
Reposted by Giulio Francesco Romiti
The Lancet @thelancet.com · 30/11/2024
Sudden and unexpected cardiac arrest or death occurs when the heart stops beating or isn't beating properly. In a new Review, authors highlight the critical need to improve methods of identifying athletes at risk of sudden cardiac arrest and death: bit.ly/4i62xFj
Figure: Sudden cardiac arrest or death in athletes—uncertainties and future points of emphasis. Copyright: 2024 Elsevier Ltd. All rights are reserved.
0175
Giulio Francesco Romiti @giuliofromiti.bsky.social · 30/11/2024
ESC Heart & Stroke 2024 has just ended - two days of great talks and discussion on heart-brain interactions. 📌 Get ready for the 2025 edition - coming to Italy! 🇮🇹 Save the date: 🗓️ 15-16 November 2025, Milan 🇮🇹 More info: esc365.escardio.org/event/1888
052
Reposted by Giulio Francesco Romiti
Henry Han @hancardiomd.bsky.social · 29/11/2024
#ArtificialIntelligence and digital tools for design and execution of CV clinical trials The landscape of #AI in clinical trial planning academic.oup.com/eurheartj/ad... #CardioEd #CardioSky @drmarthagulati.bsky.social @joyywu.bsky.social @arghavansallesmd.bsky.social @cardioobdoc.bsky.social
0124
Giulio Francesco Romiti @giuliofromiti.bsky.social · 29/11/2024
This is so relevant. #Delirium and #Frailty associated with worse outcomes in patients with acute decompensated heart failure - time to incorporate routine frailty assessment in cardiovascular medicine! @mproiettimd.bsky.social
011
Reposted by Giulio Francesco Romiti
Jason Andrade @drjasonandrade.bsky.social · 18/11/2024
Congrats to Rajeev Pathak, @prashsanders.bsky.social and team on the ARREST-AF RCT. Incredibly informative data - adjective comprehensive risk factor optimisation significantly improved post ablation AF freedom. We now have RCT evidence supporting RFM as a foundation and pillar of AF management.
0158
Reposted by Giulio Francesco Romiti
JAMA @jama.com · 28/11/2024
RCT: Transcatheter tricuspid valve repair (T-TEER) + optimized medical therapy is safe and effective in improving clinical outcomes and quality of life in patients with severe, symptomatic tricuspid regurgitation vs medical therapy alone. ja.ma/4g8j2i7
Figure 4: Surgical Curves for Patients in the T-TEER + OMT Group and the OMT-Alone Group.
0114
Reposted by Giulio Francesco Romiti
Nephrology Journal Club @nephjc.bsky.social · 20/11/2024
#NephSky can you feel your heart beating? The prevalence of atrial fibrillation (AF), the most common arrhythmia among patients on hemodialysis (HD), & steadily increases as kidney function declines 📈💔 Come see how this #NephJC story goes tonight 9 PM EST www.ahajournals.org/...
2166
Giulio Francesco Romiti @giuliofromiti.bsky.social · 28/11/2024
Hello Bluesky from Athens 🇬🇷 where ESC Heart and Stroke 2024 is taking place! The 7th Annual Conference of the ESC Council on Stroke ⤵️ esc365.escardio.org/event/1665 #Medsky #Cardiosky #Strokesky
0103
Reposted by Giulio Francesco Romiti
TH, Thrombosis & Haemostasis,TH Open @thjournal.bsky.social · 27/11/2024
🌟 We’re on Bluesky! 🌟 Follow us for latest #thrombosis, #haemostasis, and #VascularBiology research ! #MedSky #HemeSky #Thrombosis #Hemostasis #Hematology #TH
1114
Reposted by Giulio Francesco Romiti
Kirsten Bibbins-Domingo @kbibbinsdomingo.bsky.social · 16/11/2024
Welcome to BlueSky @jamacurrent.bsky.social !! Looking forward to seeing old friends & new at #AHA24 #CardioSky #MedSky
JAMA is an international peer-reviewed general medical journal now on BlueSky
716252